Improve Warfarin Therapy or Use Dabigatran for Patients with Atrial Fibrillation - A Cost-Effectiveness Analysis

被引：0
|
作者：
You, Joyce H. [1 ]
Tsui, Kia K. [1 ]
Wong, Raymond S.
Cheng, Gregory
机构：
[1] Chinese Univ Hong Kong, Sch Pharm, Shatin, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2011年 / 51卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1334 / 1334
页数：1
相关论文
共 50 条
  • [31] Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation: A Cost-Effectiveness Analysis
    Rognoni, Carla
    Marchetti, Monia
    Quaglini, Silvana
    Liberato, Nicola Lucio
    CLINICAL DRUG INVESTIGATION, 2014, 34 (01) : 9 - 17
  • [32] COST-EFFECTIVENESS OF EDOXABAN, APIXABAN, RIVAROXABAN AND DABIGATRAN VERSUS WARFARIN FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
    Marchetti, M.
    Liberato, N. L.
    Rognoni, C.
    Quaglini, S.
    HAEMATOLOGICA, 2014, 99 : 487 - 487
  • [33] Warfarin or Dabigatran in patients with atrial fibrillation
    Meinertz, T.
    Nitschmann, S.
    INTERNIST, 2011, 52 (04): : 462 - +
  • [34] Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients With Atrial Fibrillation
    Patrick, Amanda R.
    Avorn, Jerry
    Choudhry, Niteesh K.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (05): : 429 - U51
  • [35] THE COST-EFFECTIVENESS OF GENOTYPE-GUIDED WARFARIN DOSING FOR PATIENTS WITH ATRIAL FIBRILLATION
    Patrick, A.
    Avorn, J.
    Choudhry, N. K.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 181 - 181
  • [36] The Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients with Atrial Fibrillation
    Patrick, Amanda R.
    Avorn, Jerry
    Choudhry, Niteesh K.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S23 - S24
  • [37] Comparing new oral anticoagulants (dabigatran, rivaroxaban and apixaban) to warfarin in patients with atrial fibrillation, a cost-effectiveness analysis from a German payer perspective
    Krejczy, M.
    Wehling, M.
    Marx, S.
    Obermann, K.
    Harenberg, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 256 - 257
  • [38] Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation
    Seeger, John D.
    Bykov, Katsiaryna
    Bartels, Dorothee B.
    Huybrechts, Krista
    Zint, Kristina
    Schneeweiss, Sebastian
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (06) : 1277 - 1289
  • [39] Questions in the comparative effectiveness of dabigatran and warfarin in atrial fibrillation
    Alonso, Alvaro
    Lutsey, Pamela L.
    Chen, Lin Y.
    MacLehose, Richard F.
    Bengtson, Lindsay G. S.
    JOURNAL OF CARDIOLOGY, 2017, 70 (1-2) : 99 - 100
  • [40] Cost-effectiveness Analysis of Apixaban against Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation in Japan
    Kamae, Isao
    Hashimoto, Yoichiro
    Koretsune, Yukihiro
    Tanahashi, Norio
    Murata, Tatsunori
    Phatak, Hemant
    Liu, Larry Z.
    Tang, Ann C.
    Wang, Peter Feng
    Okumura, Ken
    CLINICAL THERAPEUTICS, 2015, 37 (12) : 2837 - 2851
12345